Search Results
90 items found for "Rui-Hong Zhang"
- Integrative model of the FSH receptor reveals the structural role of the flexible hinge region
extracellular domain, which contains the hormone-binding site and is linked to the transmembrane domain by the hinge
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
October 2022 "Systolic heart failure (HF) is a chronic clinical syndrome characterized by the reduction in cardiac function and still remains the disease with the highest mortality worldwide. Despite considerable advances in pharmacological treatment, HF represents a severe clinical and social burden. Chronic human HF is characterized by several important neurohormonal perturbations, emanating from both the autonomic nervous system and the adrenal glands. Circulating catecholamines (norepinephrine and epinephrine) and aldosterone elevations are among the salient alterations that confer significant hormonal burden on the already compromised function of the failing heart. This is why sympatholytic treatments (such as β-blockers) and renin-angiotensin system inhibitors or mineralocorticoid receptor antagonists, which block the effects of angiotensin II (AngII) and aldosterone on the failing heart, are part of the mainstay HF pharmacotherapy presently. The adrenal gland plays an important role in the modulation of cardiac neurohormonal stress because it is the source of almost all aldosterone, of all epinephrine, and of a significant amount of norepinephrine reaching the failing myocardium from the blood circulation. Synthesis and release of these hormones in the adrenals is tightly regulated by adrenal G protein-coupled receptors (GPCRs), such as adrenergic receptors and AngII receptors. In this review, we discuss important aspects of adrenal GPCR signaling and regulation, as they pertain to modulation of cardiac function in the context of chronic HF, by focusing on the 2 best studied adrenal GPCR types in that context, adrenergic receptors and AngII receptors (AT 1 Rs). Particular emphasis is given to findings from the past decade and a half that highlight the emerging roles of the GPCR-kinases and the β-arrestins in the adrenals, 2 protein families that regulate the signaling and functioning of GPCRs in all tissues, including the myocardium and the adrenal gland." Read more at the source #DrGPCR #GPCR #IndustryNews
- Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs)...
September 2022 Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs ; (d) RGS20 was found to be significantly associated with some tumor-related signaling pathways and long
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
April 2022 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage Sosei Group Corporation (“the Company”; TSE: 4565) today confirms that a series of Executive Management changes
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
associate with the active parathyroid hormone 1 receptor (PTH1R) in different complex configurations ("hanging Moreover, we assess β-arrestin conformational changes that are induced specifically by proximal and distal Here, we show differences between conformational changes that are induced by P-R* or R* receptor states
- Nanobodies: New Dimensions in GPCR Signaling Research
They have also been used as biosensors to monitor conformational changes of GPCRs in living cells. (New York, N.Y.), 347(6226), 1113–1117. https://doi.org/10.1126/science.aaa5026 Wu, A., Salom, D., Hong
- Newly launched antibody libraries put hard-to-drug targets within reach
The drugs also target relatively low-hanging fruit: like cytokines or tyrosine kinase receptors.
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
A rational drug discovery campaign hinges on a deep understanding of how distinct molecules interact Mutagenesis involves deliberately altering the DNA sequence of a gene to study the resulting changes framework that combined mutagenesis and structural data to contextualise ligand-induced structural changes datasets, allowing researchers to determine the functional consequences of every possible amino acid change B., Chang, B., & Peisajovich, S. G. (2017).
- Structural landscape of the Chemokine Receptor system
interaction follows a common pattern which is generally described by the classic “two-site” model (Crump, Gong Conformational changes between inactive and active states are facilitated by a "microswitch network" chemokine antagonist ([5P7]CCL5), and a small-molecule inverse agonist (maraviroc) (Tan, Zhu et al. 2013, Zheng , Han et al. 2017, Isaikina, Tsai et al. 2021, Zhang, Chen et al. 2021). , exhibits bias toward G-protein signaling, which has been structurally related to a conformational change
- Decoding β-Arrestins: from Structure to function
Following extracellular stimulus detection, receptor activation initiates conformational changes, exposing recognized for inhibiting G protein signaling, they also influence specific pathways such as MAPK signaling (Song states: methods and implications The formation of functional complexes involving GPCRs and β-arrestins hinges , as well as MAPK cascade kinases which can be activated through specific β-arrestin conformations (Song not all receptors recruit both isoforms equally and arrestins can undergo different conformational changes
- VAMP2: a crucial player in the delivery of MOR to the synapse
Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Zhang, and L. Ma. 2008.
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
the lipid composition of intracellular membranes may influence GPCR dynamics and signaling outcomes, changing Nature communications, 8(1), 443. https://doi.org/10.1038/s41467-017-00357-2 Jong, Y. Z., Wilderman, A., Katakia, T., McCann, T., Yokouchi, H., Zhang, L., Corriden, R., Liu, D., Feigin, M
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
These receptors respond to a variety of signals by undergoing structural changes that activate internal brief sequential intervals following GTP addition, the research team identified the conformational changes The captured structures reveal a dynamic of conformational changes initiated by the binding of an agonist This early interaction sets the stage for a cascade of significant conformational changes. Concurrently, the α1 helix extends, propagating structural changes throughout the G protein.
- Overview of adhesion GPCRs self-activation
Structurally they characterize by a long extracellular region of adhesion-like domains which modulate structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling, since the change , Z., Liu, C., Li, X., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
However, the receptors that these medicines target have been described as the ‘low-hanging’ fruit, and These interactions induce local conformational changes which are amplified and transmitted to the intracellular This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that the fully integrated PROcisionXᵀᴹ discovery platform Structure-based validation of Orion’s approach Zheng
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang Zhang Award Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Zhang, H., et al., Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic
- Therapeutic validation of an orphan G protein‐coupled receptor
., 2016; Zhang et al., 2016) and embelin (2,5‐dihydroxy‐3‐undecyl‐1,4‐benzoquinone) which is a natural
- G protein coupling and activation of the metabotropic GABAB heterodimer
Cryo-electron microscopy studies revealed a drastic conformational change upon activation and a unique metadynamics computations to predict the mechanism by which the inactive GP induces conformational changes
- 📰 GPCR Weekly News, April 29 to May 5, 2024
announcements in today’s episode, so join us in this celebration and be the first to know about all the changes
- SLAS2022 International Conference and Exhibition
We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person If there are any changes made that will impact our ability to hold the event in-person, we will notify
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
al. highlight the importance of GPCR dimers in drug discovery referring to important conformational changes But what are the conformation changes that drive GPCR dimerization? The interaction between two receptors in a dimer involves a conformational change in the transmembrane Interestingly, the amplitude of the conformational changes due to ligand binding is limited at these
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
characterization of biased receptors may give insights into the relationship between the conformational change protein coupling bias of mutant AVPR2s may broaden our understanding of the relationship between the changed
- Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in
We tested effects of changes in vesicle numbers undergoing fusion at single synapses, relative placement Experimental effects of Pr changes, consistent with GABAB receptor effects, were straightforwardly represented by changes in numbers of synapses. GABAB receptors alter Pr leaving synaptic properties unchanged, while 5-HT1B receptors fundamentally change
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
severe pain by activating the μ-opioid receptor (MOR), whereas naloxone, with only slight structural changes The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
Additionally, pull-down experiments demonstrated that YM promotes similar conformational changes in both Together, these results indicate that changes in membrane binding impact the ability of YM to inhibit
- 📰 GPCR Weekly News, March 20 to 26, 2023
Structural and Molecular Insights into GPCR Function Physiological changes in bilayer thickness induced Ultrafast structural changes direct the first molecular events of vision. Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting